Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Pennant Group Inc(PNTG)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PNTG
10/13/2026: PNTG (5-star) is currently NOT-A-BUY. Pass it for now.
Pennant Group Inc is a growth-oriented provider of home health, hospice, and senior living services in the U.S. The company has a leading position in its niche by leveraging a decentralized operating model that empowers local management. Its primary growth story is built on the rising demand for home-based care and strategic acquisitions of smaller agencies. However, investors must weigh these strengths against significant risks, including Medicare reimbursement volatility, healthcare labor shortages, and execution risks tied to M&A. Pennant is best suited for growth investors who can tolerate sector-specific regulatory risks, and market participants should monitor staffing trends and federal reimbursement policy closely.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company is expanding its footprint in the high-demand home health and senior care segments. |
| Momentum investor | Mixed fit | Momentum depends on sustained quarterly outperformance relative to industry benchmarks. |
| Value investor | Mixed fit | The valuation requires assessing the balance between growth potential and regulatory risks. |
| Dividend investor | Weak fit | Pennant currently reinvests all cash flow into growth rather than paying dividends. |
| Low-risk investor | Weak fit | Healthcare regulatory and reimbursement volatility creates inherent price risk. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | Small-cap healthcare stocks can experience significant swings based on reimbursement news. |
| Valuation risk | Medium | Growth expectations are already priced in, requiring consistent execution to maintain multiples. |
| Competition risk (nursing staff) | High | A shortage of skilled nursing professionals restricts capacity and increases wage expenses. |
| Business quality | Medium | The decentralized model creates strong local focus but requires rigorous corporate oversight. |
| Dividend income | Low / none | Investors should not rely on PNTG for immediate income generation. |
| Execution risk | Medium | Successfully integrating acquisitions is crucial for long-term growth and margin stability. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 117.1% | Avg. Invested days 63 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 10/13/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.42B USD | Price to earnings Ratio 44.53 | 1Y Target Price 46.83 |
Price to earnings Ratio 44.53 | 1Y Target Price 46.83 | ||
Volume (30-day avg) 373.1K shares | Beta 1.25 | 52 Weeks Range 22.25 - 42.74 | Updated Date 10/13/2026 |
52 Weeks Range 22.25 - 42.74 | Updated Date 10/13/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.91 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Home Health | Clinical nursing and therapy services provided in patient homes. | Revenue is largely driven by Medicare reimbursements for skilled medical care at home. |
| Hospice | Palliative care and comfort services for end-of-life patients. | Provides recurring, essential care services with high demand visibility. |
| Senior Living | Assisted living and memory care facilities. | Generates revenue through private-pay residential care services. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE 44.53 | Forward PE 25.45 | Enterprise Value 1.86B | Price to Sales(TTM) 1.28 |
Enterprise Value 1.86B | Price to Sales(TTM) 1.28 | ||
Enterprise Value to Revenue 1.69 | Enterprise Value to EBITDA 25.39 | Shares Outstanding 34.93M | Shares Floating 33.21M |
Shares Outstanding 34.93M | Shares Floating 33.21M | ||
Percent Insiders 5.05 | Percent Institutions 96.03 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.